X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (28) 28
oncology (27) 27
middle aged (25) 25
female (24) 24
male (24) 24
aged (22) 22
adult (20) 20
index medicus (15) 15
lung neoplasms - drug therapy (15) 15
carcinoma, non-small-cell lung - drug therapy (14) 14
lung neoplasms - pathology (14) 14
treatment outcome (13) 13
further section · weitere sektionen (11) 11
non-small cell lung cancer (11) 11
carcinoma, non-small-cell lung - pathology (10) 10
respiratory system (10) 10
aged, 80 and over (9) 9
chemotherapy (9) 9
disease-free survival (9) 9
erlotinib (9) 9
lung cancer, non-small cell (9) 9
prognosis (9) 9
survival rate (9) 9
survival analysis (8) 8
antineoplastic combined chemotherapy protocols - therapeutic use (7) 7
care and treatment (7) 7
cisplatin (7) 7
docetaxel (7) 7
neoplasm staging (7) 7
nsclc (7) 7
carcinoma (6) 6
lung neoplasms - mortality (6) 6
antineoplastic combined chemotherapy protocols - administration & dosage (5) 5
antineoplastic combined chemotherapy protocols - adverse effects (5) 5
carboplatin (5) 5
carcinoma, non-small-cell lung - mortality (5) 5
combination (5) 5
follow-up studies (5) 5
gefitinib (5) 5
gemcitabine (5) 5
guanine - analogs & derivatives (5) 5
metastasis (5) 5
pemetrexed (5) 5
protein kinase inhibitors - therapeutic use (5) 5
research (5) 5
therapy (5) 5
adenocarcinoma (4) 4
adenocarcinoma - pathology (4) 4
antineoplastic agents - therapeutic use (4) 4
bone marrow failure (4) 4
cancer (4) 4
cisplatin - administration & dosage (4) 4
disease progression (4) 4
dyskeratosis congenita (4) 4
glutamates - administration & dosage (4) 4
guanine - administration & dosage (4) 4
hematology, oncology and palliative medicine (4) 4
immunodeficiency (4) 4
lung cancer (4) 4
lung neoplasms - genetics (4) 4
lung neoplasms - metabolism (4) 4
lymphatic metastasis (4) 4
lymphopenia (4) 4
quinazolines - therapeutic use (4) 4
survival (4) 4
acquired-resistance (3) 3
adenocarcinoma - metabolism (3) 3
adenocarcinoma - mortality (3) 3
adenocarcinoma of the lung (3) 3
antimitotic agents (3) 3
antineoplastic agents (3) 3
antineoplastic agents - administration & dosage (3) 3
bibw 2992 (3) 3
carboplatin - administration & dosage (3) 3
carcinoma, non-small-cell lung - genetics (3) 3
carcinoma, non-small-cell lung - secondary (3) 3
clinical trials as topic (3) 3
clinical-trials (3) 3
double-blind method (3) 3
egfr mutations (3) 3
expression (3) 3
germany - epidemiology (3) 3
guidelines (3) 3
iii trial (3) 3
immunohistochemistry (3) 3
immunology (3) 3
lung neoplasms - surgery (3) 3
medicine, general & internal (3) 3
metaanalysis (3) 3
mutation (3) 3
mutations (3) 3
neoplasm metastasis (3) 3
oncology, experimental (3) 3
original article · originalarbeit (3) 3
paclitaxel (3) 3
pilot projects (3) 3
pilot study (3) 3
pulmonary/respiratory (3) 3
randomized-trial (3) 3
receptor, epidermal growth factor - genetics (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2009, Volume 374, Issue 9699, pp. 1432 - 1440
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 3, pp. 247 - 255
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2013, Volume 31, Issue 23, pp. 2895 - 2902
Journal Article
by Garassino, Marina Chiara and Cho, Byoung-Chul and Kim, Dong-Wan and Kim, Joo-Hang and Kim, Sang-We and Kim, Young-Chul and Mazières, Julien and Vansteenkiste, Johan and Lena, Hervé and Corral Jaime, Jesus and Gray, Jhanelle E and Powderly, John and Chouaid, Christos and Bidoli, Paolo and Wheatley-Price, Paul and Park, Keunchil and Soo, Ross A and Huang, Yifan and Wadsworth, Catherine and Dennis, Phillip A and Rizvi, Naiyer A and Paz-Ares Rodriguez, Luis and Novello, Silvia and Hiret, Sandrine and Schmid, Peter and Laack, Eckart and Califano, Raffaele and Maemondo, Makoto and Chaft, Jamie and Vicente Baz, David and Berghmans, Thierry and Surmont, Veerle and Reck, Martin and Han, Ji-Youn and Holgado Martin, Esther and Belda Iniesta, Cristobal and Oe, Yuichiro and Chella, Antonio and Chopra, Akhil and Robinet, Gilles and Soto Parra, Hector and Thomas, Michael and Cheema, Parneet and Katakami, Nobuyuki and Su, Wu-Chou and Wolf, Juergen and Lee, Jong-Seok and Saka, Hideo and Milella, Michele and Ramos Garcia, Inmaculada and Sibille, Anne and Yokoi, Takashi and Kang, Eun Joo and Atagi, Shinji and Spaeth-Schwalbe, Ernst and Nishio, Makoto and Imamura, Fumio and Gabrail, Nashat and Veillon, Remi and Derijcke, Sofie and Maeda, Tadashi and Zylla, Dylan and Kubiak, Kendra and Santoro, Armando and Uy, Ma. Noemi and Lucien Geater, Sarayut and Italiano, Antoine and Kowalski, Dariusz and Barlesi, Fabrice and Chen, Yuh-Min and Spigel, David and Chewaskulyong, Busyamas and Garcia Gomez, Ramon and Alvarez Alvarez, Rosa and Yang, Chih-Hsin and Hsia, Te-Chun and Denis, Fabrice and Sakai, Hiroshi and Vincent, Mark and Goto, Koichi and Bosch-Barrera, Joaquim and Weiss, Glen and Canon, Jean-Luc and Scholz, Christian and Aglietta, Massimo and Kemmotsu, Hirotsugu and Azuma, Koichi and Bradbury, Penelope and Feld, Ronald and Chachoua, Abraham and Jassem, Jacek and Juergens, Rosalyn and Palmero Sanchez, Ramon and Malcolm, Albert and Vrindavanam, Nandagopal and Kubota, Kaoru and Waller, Cornelius and Waterhouse, David and Coudert, Bruno and Mark, Zsuzsanna and ... and ATLANTIC Investigators
The Lancet Oncology, ISSN 1470-2045, 04/2018, Volume 19, Issue 4, pp. 521 - 536
Immune checkpoint inhibitors are a new standard of care for patients with advanced non-small-cell lung cancer (NSCLC) without tyrosine kinase or anaplastic... 
MULTICENTER | METAANALYSIS | NSCLC | ONCOLOGY | RANDOMIZED CONTROLLED-TRIAL | ATEZOLIZUMAB | IMMUNE CHECKPOINT | NIVOLUMAB | MEDI4736 | CLINICAL ACTIVITY | DOCETAXEL | Lung cancer, Non-small cell | Care and treatment
Journal Article
Forum of Clinical Oncology, ISSN 1792-345X, 2012, Volume 3, Issue 2, pp. 31 - 39
Journal Article
Journal of Cancer Research and Clinical Oncology, ISSN 0171-5216, 12/2018, Volume 144, Issue 12, pp. 2457 - 2463
Journal Article
by Schuler, Martin and Yang, J.C.-H and Park, K and Kim, J.-H and Bennouna, Jaafar and Chen, Y.-M and Chouaid, C and De Marinis, F and Feng, J.-F and Grossi, Francesco and Kim, D.-W and Liu, X and Lu, S and Strausz, J and Vinnyk, Y and Wiewrodt, R and Zhou, C and Wang, B and Chand, V.K and Planchard, D and Bagnes, Claudia and Martin, Claudio Marcelo and Recondo, Gonzalo and Zarba, Juan Jose and Blajman, Cesar and Richardet, Martín and McLachlan, Sue-Anne and Parente, Phillip and Underhill, Craig and Crombie, Catherine and Mainwaring, Paul and Greil, Richard and Humblet, Yves and Bustin, Frédérique and Carestia, Luciano and Galdermans, Danny and Lambrechts, Marc and Delval, Laetitia and Vercauter, Piet and Zhou, Caicun and Wang, Jin and Huang, Cheng and Lin, Xiaoyan and Wu, Yilong and Liu, Xiaoqing and Cheng, Ying and Qin, Shukui and Feng, Jifeng and Huang, Jianjin and Zhang, Yiping and Lu, Shun and Zereu, Manuela and Garicochea, Bernardo and Zadra, Cyntia Albuquerque and Riska, Henrik and Alanko, Tuomo and Cadranel, Jacques and Chouaid, Christos and Zalcman, Gérard and Sibilot, Denis Moro and Perol, Maurice and Planchard, David and Bennouna, Jaafar and Fournel, Pierre and Gervais, Radj and Rotarski, Maciej and Coudert, Bruno and Thomas, Michael and Wehler, Thomas and Faehling, Martin and Keilholz, Ulrich and Laack, Eckart and Von Pawel, Joachim and Huber, Rudolf and Dickgreber, Nicolas and Wiewrodt, Rainer and Mark, Zsuzsanna and Tehenes, Sandor and Strausz, Janos and Sarosi, Veronika and Prabhash, Kumar and Jain, Minish and Venkatesan, Srinivasan and Sharma, Lalit and Dadhich, Hemant and Nagarkar, Rajnish Vasant and Onn, Amir and Gottfried, Maya and Stemmer, Solomon and Migliorino, Maria Rita and Bidoli, Paolo and Bearz, Alessandra and Gridelli, Cesare and Milandri, Carlo and Platania, Marco and Ceresoli, Giovanni Luca and Cruciani, Giorgio and Delgado, Francisco Gutierrez and Perez, José Luis Gonzalez and Luna, Gabriela Alvarado and ... and Lux-Lung 5 Investigators and LUX-Lung 5 Investigators
Annals of Oncology, ISSN 0923-7534, 03/2016, Volume 27, Issue 3, pp. 417 - 423
Journal Article
Journal Article
Journal Article
Deutsches Arzteblatt International, 6/2008, Volume 105, Issue 25, pp. 457 - 457
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 12/2008, Volume 3, Issue 12, pp. 1446 - 1453
Relationships between clinical outcomes and epidermal growth factor receptor (EGFR)-related tumor markers were investigated in patients with advanced non-small... 
EGFR mutations | Erlotinib | Epidermal growth factor receptor (EGFR) | EGFR gene copy number | Non-small cell lung cancer | Non-small cell cancer | GEFITINIB | ACTIVATED PROTEIN-KINASE | TYROSINE KINASE | SENSITIVITY | TRIAL | THERAPY | GENE | ONCOLOGY | RESPIRATORY SYSTEM | PREDICTORS | MUTATIONS | EXPRESSION | Erlotinib Hydrochloride | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | ras Proteins - genetics | Phosphorylation | Proto-Oncogene Proteins p21(ras) | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - metabolism | Humans | Lung Neoplasms - metabolism | Middle Aged | ras Proteins - metabolism | Male | Immunoenzyme Techniques | Receptor, Epidermal Growth Factor - metabolism | Adenocarcinoma - metabolism | Aged, 80 and over | Biomarkers, Tumor - metabolism | Adult | Female | Adenocarcinoma - genetics | Proto-Oncogene Proteins c-akt - metabolism | Lung Neoplasms - genetics | Proto-Oncogene Proteins - metabolism | Carcinoma, Non-Small-Cell Lung - genetics | Carcinoma, Non-Small-Cell Lung - metabolism | In Situ Hybridization, Fluorescence | Proto-Oncogene Proteins - genetics | Survival Rate | Treatment Outcome | Gene Dosage | Mutation - genetics | Adenocarcinoma - drug therapy | Disease-Free Survival | Carcinoma, Squamous Cell - drug therapy | Protein Kinase Inhibitors - therapeutic use | Quinazolines - therapeutic use | Aged | Biomarkers, Tumor - genetics | Carcinoma, Non-Small-Cell Lung - drug therapy | Germany | Mitogen-Activated Protein Kinases - metabolism
Journal Article